Opt-Out Rights Sample Clauses

POPULAR SAMPLE Copied 1 times
Opt-Out Rights. 10.1 TU will ensure that all enrolling/re-enrolling students are given appropriate information about data sharing including a right to opt out of the sharing for the purposes set out in this Data Sharing Agreement. This will be communicated by way of TU’s Student Privacy Notice. 10.2 TUSU are required to maintain a readily accessible and easy to use mechanism for students to opt out of having their Personal Data processed by TUSU at any time. 10.3 If a student notifies TU that they wish to opt out of their Personal Data being shared with ▇▇▇▇, TU will notify TUSU and their Personal Data will no longer be included in the transfer. 10.4 Where a student exercises their right to opt out of SU membership, after their personal data has been shared with TUSU, TUSU will ensure that it or any Data Processors working on its behalf, destroy and cease processing any Personal Data already received without delay.
Opt-Out Rights. The Long Form Notice shall inform Settlement Class Members that they have the right to opt out of the Settlement. The Long Form Notice shall provide the deadlines and procedures for exercising this right.
Opt-Out Rights. (a) The Class Notice shall permit Settlement Class Members to exclude themselves from the Settlement Classes and not to be bound by this Agreement, if, within such time as is ordered by the Court and contained in the Class Notice, the Settlement Class Member either: (i) signs and mails a notice of intention to opt out to the Settlement Administrator (in no particular format, but which contains the Settlement Class Member’s name, address, and telephone number and the words “opt out,” “exclusion,” or words to that effect clearly indicating an intent not to participate in the settlement); or (ii) completes and electronically submits the opt-out form on the Settlement Website. If there is more than one account holder on an Account, all account holders must execute the notice of intention to opt out for the opt-out to be effective. If necessary, the Parties shall confer as to whether a communication from a Settlement Class Member is a request to opt out, and shall inform the Court of their position at the Final Approval Hearing. In no event shall any notice in which a Settlement Class Member purports to opt out any other person (including any group, aggregate, or class involving more than one Settlement Class Member) be considered a valid opt-out. Individuals are not permitted to exclude other individuals, and if there is a group of opt-outs, each individual Settlement Class Member must evidence his or her intent by complying with the procedures above. Any opt-out submitted by a Settlement Class Member on behalf of a group, aggregate, or putative class shall be deemed valid as to that Settlement Class Member only, and shall be invalid as to the group, aggregate, or putative class. (b) The Class Notice shall provide that requests by any Settlement Class Member to opt out of the Settlement must either be (i) mailed to the Settlement Administrator postmarked by the Opt-Out and Objection Deadline, or (ii) submitted on the Settlement Website by the Opt-Out and Objection Deadline, or be forever barred. (c) The Settlement Administrator must send Bangor’s counsel and Class Counsel copies of any opt-out notices it receives within seven (7) days of receipt. Bangor’s Counsel or Class Counsel may dispute an opt-out or purported opt-out, including an attempt to opt out as a group, aggregate or class. Such objection shall be effective to void any opt-out or purported opt-out unless and until there is a ruling by the Court that the objection should be rejected or overruled. T...
Opt-Out Rights. Each Holder shall have the right, at any time and from time to time (including after receiving information regarding any potential public offering), to elect to not receive any notice that the Company or any other Holders otherwise are required to deliver pursuant to this Agreement by delivering to the Company a written statement signed by such Holder that it does not want to receive any notices hereunder (an “Opt-Out Request”); in which case and notwithstanding anything to the contrary in this Agreement the Company and other Holders shall not be required to, and shall not, deliver any notice or other information required to be provided to Holders hereunder to the extent that the Company or such other Holders reasonably expect would result in a Holder acquiring material non-public information within the meaning of Regulation FD promulgated under the Exchange Act. An Opt-Out Request may state a date on which it expires or, if no such date is specified, shall remain in effect indefinitely. A Holder who previously has given the Company an Opt-Out Request may revoke such request at any time, and there shall be no limit on the ability of a Holder to issue and revoke subsequent Opt-Out Requests; provided that each Holder shall use commercially reasonable efforts to minimize the administrative burden on the Company arising in connection with any such Opt-Out Requests.
Opt-Out Rights. 1. Opt-Out Requirements (a) files or has filed a separate action against any of the Released Parties, or (b) is, or becomes, a putative class member in any other class action filed against any of the Released Parties.
Opt-Out Rights. The Class Notice shall inform Class Members that they have the right to opt out of the Settlement. The Class Notice shall provide the deadlines and procedures for exercising this right.
Opt-Out Rights. You have the right to opt-out and not be bound by the arbitration and class action waiver provisions set forth above by sending written notice of your decision to opt-out to ▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇. The notice must be sent within 30 days of your Account creation, otherwise you shall be bound to arbitrate disputes in accordance with the terms of those paragraphs. If you opt-out of these arbitration provisions, Section 7.3 will be deemed void and removed from this Agreement.
Opt-Out Rights. Either Party may elect to discontinue (a “Discontinuing Party”) joint research on, development and commercialization of a Clinical Development Candidate or a Cell Therapy Product upon six (6) months prior written notice (“Opt-Out Notice”) to the other Party; provided that the effective date of either Party’s election to opt out shall not be prior to the completion of the first Phase I Study conducted by the Parties hereunder, and provided further that neither Party shall be relieved of its obligations to pay for its share of Clinical Development Costs for a clinical study that is ongoing at the effective date of a Party’s election to opt-out with respect to the applicable Clinical Development Candidate. Notwithstanding the foregoing, if a Party is unable to pay any or all of its portion of Clinical Development Costs when due, such Party shall be deemed to have delivered an Opt-Out Notice on the date such payment was due. Upon delivery of the Opt-Out Notice, the subject Clinical Development Candidate or Cell Therapy Product shall be deemed a “Rejected Product.” The Discontinuing Party shall be required to continue co-funding all of its activities under this Strategic Alliance Agreement during such six (6) month notice period (subject to the first sentence of this Section 6.1). Upon receipt of an Opt-Out Notice for a Clinical Development Candidate or Cell Therapy Product, the non-discontinuing Party shall have the option (the “Sole Development Option”), exercisable by providing written notice to the Discontinuing Party by the end of such six (6) month period, to continue the development and commercialization of such Rejected Product in the Therapeutic Field (and in such event, Table of Contents such Rejected Product shall thereafter be referred to as a “Sole Development Product”), at its own expense. Upon the exercise of such option, the non-discontinuing Party shall be deemed the “Developing Party,” and the Developing Party shall be released from its exclusivity obligations set forth in Section 2.5 above with respect only to such Sole Development Product. The Parties shall have the following rights and obligations upon exercise of the Sole Development Option: (a) if Angiotech is the Developing Party, such Sole Development Product shall continue to be considered a Clinical Development Candidate or Cell Therapy Product (as applicable) for purposes of the Transaction Agreements; provided, however that (i) the provisions of Section 2.4 and ARTICLES III, V, VII ...
Opt-Out Rights. 11.1. A potential Settlement Class Member who wishes to opt out of the Settlement Class must complete and send to the Settlement Administrator a Request for Exclusion that is postmarked no later than the Opt Out Deadline. The Request for Exclusion must: (a) identify the name and address of the potential Settlement Class Member requesting exclusion; (b) provide the cell phone number at which that potential Settlement Class Member was called by Ocwen during the Settlement Class Period; (c) be personally signed by the potential Settlement Class Member requesting exclusion; and (d) contain a statement that reasonably indicates a desire to be excluded from the Settlement. 11.2. Any potential member of the Settlement Class who properly opts out of the Settlement Class shall: (a) not be bound by any orders or judgments relating to the Settlement;
Opt-Out Rights. 11.1 A Settlement Class Member who wishes to be excluded from the Settlement Class must do so in writing. In order to opt out, the Class Member must send to the Settlement Administrator, at the address listed in the Notice and on the Settlement Website, a written request to opt out that is postmarked no later than the Opt-Out Deadline, as specified in the Notice. The request to opt out must: (a) identify the case name; (b) identify the name and address of the person requesting exclusion; (c) be personally signed by the person requesting exclusion; (d) contain a statement that indicates a desire to be excluded from the Settlement Class, such as “I hereby request that I be excluded from the proposed Settlement Class”; and (e) affirm via sworn statement that the individual had valid and unexpired DACA status at the time he or she was denied a loan from Discover. If requested, the opt-out request must also include Official Documentation evidencing the Settlement Class Member’s valid and unexpired DACA status at the time of the denial of the application. Mass or class opt outs shall be void. 11.2 Any Settlement Class Member who does not opt out of the Settlement in the manner described herein shall be deemed to be part of the Settlement Class upon the expiration of the Opt- Out Deadline and shall be bound by all subsequent proceedings, orders and judgments.